| 11 Dec, 08:42 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial". | nse |
| 01 Dec, 08:54 am | — | … | Update on the Company's Chhatrapati Sambhajinagar (Aurangabad) Facility | nse |
| 27 Nov, 10:15 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Update On The Company''s Monroe, North Carolina (USA) Facility | bse |
| 27 Nov, 10:15 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 27, 2025, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Monroe facility". | nse |
| 25 Nov, 09:00 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 25 Nov, 08:59 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 25, 2025, titled "Glenmark Pharmaceuticals Announces Launch of Nebzmart® GFB Smartules® and GlenmarkAirz® FB Smartules®, World s First Nebulized Triple Therapy for COPD". | nse |
| 19 Nov, 05:17 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 19 Nov, 05:17 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 18 Nov, 02:40 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Nov, 02:40 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 18, 2025, titled "Cosmo and Glenmark Announce Market Authorization of Winlevi® (clascoterone) 10 mg/g cream for Treatment of Acne in 15 countries in Europe ". | nse |
| 17 Nov, 01:01 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 17 Nov, 01:01 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 14 Nov, 06:12 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 14 Nov, 06:12 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 14 Nov, 06:04 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 Nov, 06:04 pm | — | … | Press Release and Management Discussion & Analysis - Q2FY26 Results | nse |
| 14 Nov, 05:56 pm | — | … | Glenmark Pharmaceuticals Limited has submitted to the Exchange, Unaudited Financial Results (Standalone and Consolidated) for the Second Quarter and Half Yearended 30th September, 2025. | nse |
| 14 Nov, 03:34 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange about Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 | nse |
| 10 Nov, 03:30 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Nov, 03:30 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Glenmark Secures China Approval For RYALTRIS®, Reinforcing Respiratory Innovation Leadership". | nse |
| 04 Nov, 08:59 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Nov, 08:57 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 04, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial". | nse |
| 03 Nov, 05:34 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2025 | bse |
| 01 Nov, 12:07 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange about Completion of transfer of Company's Consumer Care business | nse |
| 23 Oct, 09:15 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Oct, 09:14 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 23, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40 mg/20 mL (2mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 mL (10 mg/mL) Single-Dose Vials". | nse |
| 26 Sept, 11:09 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange that the Board approves Dividend and as intimated earlier Record date for the purpose of Dividend is 03-Oct-2025. | nse |
| 26 Sept, 11:04 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Corporate Action-Board approves Dividend | bse |
| 26 Sept, 10:48 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th September, 2025 | bse |
| 26 Sept, 10:48 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on September 26, 2025, declared Interim Dividend of 2.5 per equity share. | nse |
| 24 Sept, 03:39 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Sept, 03:39 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 24, 2025, titled "Glenmark Strengthens Oncology Portfolio with Hengrui s HER2 Targeting ADC For Multiple Regions". | nse |
| 22 Sept, 05:44 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange that Revised Record date for the purpose of Dividend is 03-Oct-2025. | nse |
| 22 Sept, 05:40 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Revision In Intimation Of Record Date For Interim Dividend | bse |
| 22 Sept, 04:11 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 30-Sep-2025. | nse |
| 22 Sept, 04:06 pm | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Intimation for Considering And Approving Payment Of Interim Dividend | bse |
| 19 Sept, 10:33 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange about Credit Rating | nse |
| 19 Sept, 10:29 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 15 Sept, 05:21 pm | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange about update on Transfer of the Company's Consumer Care business | nse |
| 09 Sept, 08:53 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Intimation Regarding Upfront Payment Received | bse |
| 09 Sept, 08:48 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange about General Updates | nse |
| 05 Sept, 09:48 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Sept, 09:46 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 05, 2025, titled "Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer". | nse |
| 02 Sept, 10:29 am | — | … | Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 02, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials". | nse |
| 02 Sept, 10:27 am | — | … | Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |